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ABSTRACT
Using the human bacterial artificial chromosome
(BAC) fingerprint-based physical map, genome
sequence assembly and BAC end sequences, we
have generated a fingerprint-validated set of 32 855
BAC clones spanning the human genome. The
clone set provides coverage for at least 98% of the
human fingerprint map, 99% of the current assembled
sequence and has an effective resolving power of
79 kb. We have made the clone set publicly available,
anticipating that it will generally facilitate FISH or
array-CGH-based identification and characterization
of chromosomal alterations relevant to disease.
INTRODUCTION
Large insert bacterial artificial chromosome (BAC) (1) finger-
print maps have been developed for several organisms to
create genome-ordered clone resources and often to provide
resources for DNA sequencing efforts. For example, using
BAC fingerprinting technology (2,3) we have generated for
human (4), mouse (5), rat (6), cow (unpublished data) and
other organisms, genome maps that each offer up to 15-
fold redundant coverage (on average, each region of the
map is represented by 15 clones). Coverage redundancy is
critical to achieving map contiguity and is used to provide
evidence that individual clones are not cloning artefacts but
high fidelity representations of the underlying genome. In
genomic regions of single clone coverage this assurance is
lacking, and indeed at least one report suggests that individual
BACs may rearrange with a frequency of 10% (7). For
mammalian-sized genomes, the number of clones finger-
printed to achieve a reasonable level of map contiguity is
large. For example, in the case of the human BAC fingerprint
map, more than 415 000 clones were fingerprinted (4). In the
case of the mouse BAC fingerprint map, more than 300 000
clones were fingerprinted (5).
After maps are constructed, redundancy is unnecessary for a
complete representation of the genome and most map driven
sequencing efforts use the map to select a tiling set of clones
that, as completely as possible, represent the map and therefore
the underlying genome. For a typical mammalian genome,
assuming 200 kb clone inserts, approximately 21 000 clones
are sufficient to represent the genome. A clone set of this size
is a substantial reduction from the size of the parent library or
libraries used to construct the map. Such tiling sets have uses
other than fuelling sequencing efforts. They lend themselves to
a number of applications, ranging from focused studies on the
structure and function of individual genes and gene families to
fluorescence in situ hybridization and BAC array comparative
genomic hybridization (8,9). These latter applications are
particularly important for biomedical research.
We report here the results of our efforts to select a tiling set
of clones representing the human genome. We used the avail-
able BAC fingerprint map, BAC end sequences and genome
sequence in our clone selection process. We assessed the
selected clones for coverage of the genome sequence and
fingerprint map, and have made available online views of
the clone set in the context of the map from which the clones
were selected. The clone set has been rearrayed and is avail-
able from BACPAC Resources (bacpac.chori.org/pHuman-
MinSet.htm). The set has been used to make high-density
microarrays for BAC array CGH (10). Detailed information
about the clones in the set is available at mkweb.bcgsc.ca/
bacarray.
MATERIALS AND METHODS
Map-based BAC set construction
For selection of clones, we used the human BAC fingerprint-
based physical map (4) generated at Washington University
Genome Sequencing Center. Clones were chosen from each of
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the 726 contigs to provide maximum coverage of the finger-
print map. Clones not assigned to contigs as well as buried (i.e.
without a unique complement of fingerprint digest fragments)
clones (11,12) were excluded from candidacy. We restricted
our clone selection exercises to the readily available RPCI-11
(7), RPCI-13 (7) and Caltech D1/D2 (informa.bio.caltech.
edu/Bac_info.html) libraries. The algorithm for clone selec-
tion was based on a clone-walking methodology, and each
fingerprint map contig was treated independently. For each
map contig, the starting set of clones eligible for selection
consisted of the ordered set of clones assigned to the contig.
The order of the clones was previously determined by the
process of automated map creation (11,12) and subsequent
manual curation at Washington University Genome Sequen-
cing Center (www.genome.wustl.edu/projects/human). For our
application, the availability of correctly ordered clones was
key. Starting from the left end of each map contig, the first
canonical (i.e. containing a unique complement of fingerprint
digest fragments) clone from the ordered set was always
selected. The next selection was chosen to have as close
to, but no fewer than, four conserved bands with the previous
selection. Conserved bands are defined as bands present in
the fingerprints of two overlapping clones and in the finger-
prints of all clones located between them. Conserved bands
emanate from the same DNA and their use minimizes false
positives in determining clone overlap, since bands found in
multiple adjacent intermedial clones in the ordered map
represent the same digest fragment. Clones <100 kb or
>200 kb, or having fewer than 20 or more than 50 HindIII
fragments were chosen only where map coverage could not
be provided by other eligible clones. No clones <15 kb or
with fewer than 5 HindIII fingerprint fragments were
chosen. To assist with positioning the selected BACs
on the genome sequence assembly, those clones with infor-
mative BAC end sequence (BES) (13,14) records (i.e. con-
taining sufficient non-masked content with unambiguous
sequence hits to the July 2003 genome assembly) were
selected preferentially in regions where the extent and
depth of coverage would not be negatively impacted. Clones
with BES hit coordinates that were inconsistent with their
position in the fingerprint map were avoided in cases where
equivalent map coverage could be obtained by selecting
another clone. During the selection process, we aimed to
enrich, again where possible, the clone set with clones having
either existing FISH information (15,16) or sequence data.
Gaps in clone set coverage identified by sequence coordinate
analysis were addressed by selecting additional clones that
spanned these gaps.
Clone validation and replacement
After the first round of map-based clone selection, which
yielded 29 035 clones, all clones were digested using HindIII
and fingerprints were generated as described elsewhere (2,3).
Identification and sizing of bands in the clones’ fingerprints
was performed using BandLeader (17). All validation finger-
prints were compared in an automated fashion to those stored
in the physical map. In contrast to the validation fingerprints,
the fingerprints in the map are sanitized—all fragments closer
than 7 standard mobility units (this length unit corresponds to a
size tolerance of 0.5% at 5 kb, 3% at 20 kb, 5% at 25 kb) have
been replaced with a single fragment (4). This sanitization
process, motivated by the historical difficulty in determining
automatically restriction fragment copy number for multiple
co-migrating fragments (multiplets), artificially lowers the
apparent clone size by up to 30%. The validation fingerprints
did not require sanitization, due to the availability of our new
band calling software technology (17). The fingerprint com-
parison was made on the basis of the Sulston score (18), which
corresponds to the probability that two fingerprints share simi-
lar fragments by chance. Each matching validation clone fin-
gerprint was assigned a rank, from 1 to 10, indicating the
strength of the match with the corresponding map clone fin-
gerprint. Clones in the set with rank n had n  1 map clones
which were more similar than the expected map clone. Fin-
gerprints of clones with a rank over 3 were visually examined
(5272 clones). Fingerprints for 1978 clones in the set did not
match their corresponding fingerprints in the physical map.
The discrepancies could be categorized as resulting from clone
tracking errors either during the generation of the fingerprint
map or in the generation of our rearrayed clone set, from cross-
well contamination, or from situations in which the validation
fingerprinting process failed.
A second round of clone selection was performed to main-
tain the coverage represented by the 1978 failed clones. For
each failed clone, neighboring clones were selected from the
map to provide equivalent coverage. In total, 4531 clones were
selected from the fingerprint map as replacements. These
clones were sampled from RPCI-11, RPCI-13 and Caltech-D,
in roughly the same proportion as for the final set (87%:
8%:5%). An additional 1258 clones were selected to close
gaps >10 kb based on the June 2002 UCSC assembly (hg12).
Approximately 755 of these clones were not in the physical
map. A second round of fingerprint verification performed on
the replacement clones identified 413 clones that did not match
their map fingerprints. These clones were rejected from the set.
The v1.0 set contains 32 432 validated clones and is available
through BACPAC (www.chori.org/bacpac/pHumanMin-
Set.htm). Since the release of v1.0 we have removed 18 clones
from the set, on account of poor fingerprint validation, and
added an additional 441 clones to address gaps in coverage
based on the July 2003 UCSC assembly (hg16). With these
additions, the v1.1 set contains 32 855 clones.
Map coverage and representation validation
Map coverage was determined by analysing the total number
and depth of cbmap units [a cbmap unit is equivalent to a
detected and confirmed restriction fragment, regardless of
fragment size (11,12)] that were covered by the clone set
and the overlap distribution between map-adjacent clone
selections. Coverage of cbmap units was determined by par-
titioning the cbmap scale into regions which were covered by
(i) map clones, (ii) clones derived from the sampled libraries
(RPCI-11, RPCI-13 and Caltech-D) and (iii) clones belonging
in the clone set. The regions of coverage were treated as
partitions on the cbmap scale and were compared using set
operations such as union, intersection and difference to deter-
mine map representation and to identify gaps in coverage.
Overlap between map-adjacent clones in the set was calcu-
lated by computing the number of shared fragments, number
of conserved fragments and the Sulston score between the
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clones. For cases where the number of shared fragments was
fewer than 8, and the number of conserved fragments was
fewer than 4 and the total size of shared fragments was <30 kb,
overlap was considered weak and the clones were considered
non-overlapping in the context of their map position.
To determine the overall representation of the fingerprint
map in our clone set, all remaining canonical clones from
the map that were not selected were compared to the selected
set. For each map clone, the top 10 hits to the clone set, as
ranked by the Sulston score, were extracted and the top hit in
the same contig was identified as the closest match. Finger-
prints were compared using a standard mobility tolerance of 7.
The number of shared bands, overlap and Sulston score
between the map clone and its closest match in the clone
set was examined.
Sequence coverage
Sequence coverage was calculated by first determining precise
sequence coordinates for as many clones as possible. The
validation fingerprints of the clones were used to localize
them to the genome in the following manner: for each
clone, the region of the sequence from which the clone was
derived was determined using the clone’s map neighbours with
BAC end sequence (13,14) hits. Five left map neighbours and
five right map neighbours were identified and their BES hits
were used to demarcate a region of the genome. Only neigh-
bours whose BES hits landed on the same chromosome as
the majority of the clones in the map contig were used. The
clone’s own BES hits were not used in determining the
sequence region in case the clone’s map position was incorrect
or the BES hit coordinates did not reflect the actual position of
the clone or were actually associated with another clone. The
clone neighbourhood was enlarged by 1 Mb in both directions
to minimize the effect of local inconsistencies. The neighbour-
hood assembly was digested in silico and the fingerprint of a
sliding window of 120 fragments, created every 20 fragments,
was matched to the clone’s fingerprint. For the window posi-
tion which corresponded to an in silico fingerprint that
matched the most fragments, a sliding subwindow, having
1.4 times more fragments than the clone, was created every
5 fragments. The fingerprint matching was performed with a
tolerance of 2% for fragments <10 kb, 3% for fragments
10–15 kb, 4% for fragments 15–25 kb and 5% for fragments
>25 kb. This tolerance profile approximates a standard mobi-
lity tolerance of 7, the cutoff used to generate the fingerprint
map. The subwindow which matched the most fragments was
used to determine the clone coordinates. The clone was initi-
ally determined to start/end at the first fragment which was
part of a 7 matched-fragment run which started with at least
two matching fragments and had no more than 2 unmatched
fragments. The end positions were subsequently refined by
attempting to match fragments found in the clone’s fingerprint
which did not match the in silico digest from the demarcated
sequence region to in silico fragments flanking the ends. We
allowed for the detection of junction fragments, comprising
both clone insert and a portion of the vector, by transforming
each unmatched flanking in silico fragment by adding the edge
fragments of the vector. These in silico anchors were accepted
only in cases which satisfied all of the following: (i) over 70%
of the fragments in the anchor matched the clone’s fingerprint,
(ii) the size of the anchor was between 0.2 and 2.0 times the
clone’s size, (iii) the anchor contained at least 15 matching
fragments and (iv) the anchor fragment density, defined as the
ratio of matching fragments to all fragments, excluding unde-
tectable fragments (<600 bp) and poorly sized fragments
(>30 kb), was at least 0.6. The final sequence coordinate
for a clone was taken as the BES coordinates, assembly coor-
dinates, or in silico coordinates, in this order of priority.
To assist in determining coverage by the clones in the set
representing regions for which sequence coordinates could not
be determined, the fingerprint map was used in the following
manner: for every fingerprint map contig, an undirected graph
of overlapping clones was created, separating the contig into
strongly connected components. Two clones shared an edge in
the same component if they had at least 4 conserved bands and
were overlapped by more than 5 cbmap units. Clones which
were not overlapped by 5 cbmap units had to share at least
6 conserved bands. For each strongly connected component,
the leftmost and rightmost clone with sequence coordinates
was used to locate the component within the assembly and this
region was considered covered by the clone set.
Rearraying
The initial set of 29 035 clones was rearrayed at the Genome
Sciences Center, Vancouver, BC, using a QPix colony picking
platform (Genetix). The additional 5789 replacement clones
were rearrayed manually at BACPAC Resources, Children’s
Hospital Oakland Research Institute (5174 RPCI-11 and
RPCI-13 clones) and at the Genome Sciences Center (615
Caltech-D clones).
The rearraying of replacement clones from RPCI-11 and
RPCI-13 libraries was performed in two steps to minimize
manual operational error, well to well cross-contamination
and non-growth wells. Clones for each library were first
coordinated in 96-well format in the order of plate, row and
column. BACs were inoculated, grown in 96 deep well blocks
and kept at 80C until all clones were rearrayed. The BACs
were then condensed into 384-well plates using 96-pin tools.
RESULTS
Clone selection
An important resource for the initial selection of the clones
was the human BAC fingerprint map (4). The fingerprint map
is a manually curated and mature dataset which covers >99%
of the genome at an average depth of 15X. We used the
redundancy of clone coverage to specify desired clone overlap
and size characteristics with the goal of achieving the best
representation possible of both the fingerprint map and the
genome sequence. We did not place special emphasis on
selecting a ‘minimal’ tiling set, as was attempted for sequen-
cing the genome, but instead restricted the number of clones
selected to the number (approximately 30 000) that could read-
ily be placed on glass slide ‘microarrays’ with existing slide
printing technology. As a result, there are some clones in the
set that overlap extensively with their neighbours. The extent
of all clone overlap relationships is known.
We created the clone set from 3 of the 18 libraries used
to construct the fingerprint map: RPCI-11 (7), RPCI-13 (7)
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and Caltech D1/D2 (informa.bio.caltech.edu/Bac_info.html).
Clones from these libraries make up 98% of the 415 583 clones
in the fingerprint map, 96% of the 158 082 canonical map
clones assigned to contigs and 74% of the clones in the ‘tiling
path’ set of clones that contribute 79% to the finished human
genome sequence (19). Central to our purpose of creating a
public clone resource, clones from these libraries are readily
accessible to the scientific community.
Clone validation
Following rearraying, each clone in the set was assayed to
confirm its identity and to provide data for localizing the clone
in the genome. The first round of clone selection yielded
29 035 clones, representing 99% of the fingerprint map (Mater-
ials and Methods). Matches for all clones whose validation
fingerprints matched the corresponding map fingerprints
poorly (5272 clones) were examined manually (Materials
and Methods). This included 2784 clone fingerprints identified
by automated analysis as potential mismatches. The manual
review revealed 1978 clones with verification fingerprints that
did not match their map counterparts. This group of clones was
considered ineligible for inclusion within the clone set, and
consisted of 1143 clones that did not match the fingerprints in
the human fingerprint map and 835 clones with fingerprints
indicative of various technical failures, including cross-well
contamination, or gross insert deletion. To maintain coverage
in areas represented by these failed clones and fill in sub-
sequently identified sequence coverage gaps, an additional
5789 BACs were selected and fingerprint-verified. Following
the rearraying of replacement clones and fingerprint match ver-
ification, 413 clones failed the validation procedure and were
removed from the clone set. Through analysis of the clone set
coverage of the most recent sequence assembly (UCSC, hg16,
July 2003) and fingerprint map data (WashU Genome Sequen-
cing Center, September 17, 2003), we have selected an addi-
tional 441 clones to replace previously failed clones and to fill in
newly detected coverage gaps. This second round of replace-
ments clones is currently undergoing fingerprint verification.
The majority of the clones in the current 32 855 clone version of
the set are from RPCI-11 (92%) with the remaining 2% from
RPCI-13 and 6% from Caltech D libraries.
Properties of the clone set
Out of a total of 32 855 clones in the validated set, 32 209
(98%) are represented in the fingerprint map, with 31 990 of
these localized to contigs. The 646 clones not found in the
fingerprint map were selected, based on the sequence assembly
coordinates of their BES matches, to provide coverage of the
sequence assembly. Based on analysis of our validation fin-
gerprints, the average clone size and HindIII fragment counts
for each library are 189 kb/46 (RPCI-11), 160 kb/37 (RPCI-
13) and 146 kb/35 (Caltech-D). The average sizes of the clone
set members based on BES data are 176 kb for RPCI-11 clones
and 140 kb for Caltech-D, indicating that the sizes of the
validation fingerprints overestimate the sequence-predicted
sizes by 4–7%. This difference is in part due to the fact
that HindIII does not cleave the BAC DNA at the precise
cloning site employed during library construction, but instead
results in fingerprints containing vector–insert junction frag-
ments of unpredictable size.
During our selection procedure, we preferentially selected
clones which had sequence accessions (BES records or insert
sequence) or prior FISH data. Genbank (20) sequence acces-
sions, excluding BES records, were available for 7345 clones
in the set. Of these, the records indicated that 5196 clones were
finished, 2014 clones were in the working draft form, 121
clones were in progress and 533 clones had been sequenced
to low coverage. Paired-end BES coordinates or assembly
coordinates were available for 15 486 of the clones (47% of
clones in the set), providing a scaffold for localization of
clones, including those without sequence information. In




We mapped the location of 96% of the clones in the set onto
the genome sequence (UCSC, hg16, July 2003). 12 598 of the
clones in the set were unambiguously positioned in the
genome based on comparison of their BAC end sequences
to the genome sequence and 2888 based on their coordinates
in the sequence assembly. The remaining 16 200 clones were
mapped onto the genome assembly by comparing their finger-
print patterns to computer-generated fingerprints derived from
the genome sequence (in silico fingerprint mapping; Materials
and Methods). This process was facilitated by the large frac-
tion of clones (47%) that were mapped onto the genome by
virtue of BES alignments or other sequence data, and by the
generally accurate and lengthy BAC fingerprint contigs con-
tained in the human map (4). The key to accurate and reliable
in silico mapping involved identifying, for each clone to be
mapped, neighbouring flanking clones within map contigs that
were linked to the sequence through BES alignments. These
flanking clones were used to demarcate the neighbourhood
of the sequence assembly to which the mapping was applied
(sequence coverage; Materials and Methods). Using this
approach, mapping against the entire genome was generally
not required, thus substantially reducing the complexity of the
clone localization problem by focusing the exercise to the
local neighbourhood defined by the flanking clones.
To validate our in silico fingerprint mapping clone localiza-
tion approach, we examined the set of 11 763 clones that were
localized in the sequence by both BES hits and by in silico
mapping. Genomic intervals defined strictly by alignments of
the clone validation fingerprints to the in silico fingerprints
derived from the genome sequence were generally accurate,
with 11 620/11 763 (99%) of the in silico mappings over-
lapping with BES intervals. In silico-calculated clone spans
averaged 7 kb less than the lengths of the corresponding inter-
vals for the same clones as defined by BES alignments to the
genome sequence. This difference is due to the conservative
nature of the in silico localization algorithm (Materials and
Methods), which tends to yield coordinates which are sub-
sumed by the interval formed by the BES hits. The median
differences in left end, middle and right end alignments to the
genome and the 90 percentile ranges, comparing the in silico
and BES coordinates, were 1.3 (11 to 9) kb, 0.1 (11 to 9)
and –1.8 (20 to 8) kb. Negative values indicate that the BES
coordinate was to the left of the in silico coordinate. Distribu-
tions of these differences across the clone set are shown in
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Figure 1. On average, 98% of a clone’s in silico coordinate
interval overlapped with the BES coordinates, and on average
95% of the BES coordinate overlapped with the in silico
interval. In only 35/11 620 cases did the in silico coordinate
interval overlap by less than half of its extent with the BES
coordinate. The average proportion of sequence-confirmed
restriction fragments for these cases was 0.85, compared to
0.96 for the 11 620 clones in the test set.
In only 143 cases was the BES coordinate located outside of
the coordinate specified by in silico mapping. In 35 of these
cases, the coordinates were mapped to the same chromosome,
with an average distance between the closest ends of the two
coordinates of 85 kb. In the remaining 108 cases, the BES and
in silico mappings were assigned to different chromosomes.
We speculate that these inconsistencies are due to ambiguous
coordinate assignment in regions containing repeats or seq-
uence assembly gaps, and possibly also to laboratory tracking
errors causing misidentification of the BES records.
In total, either BES, in silico or assembly coordinates exist
for 31 686 clones in the set. For the 1169 remaining clones
precise sequence coordinates could not be unambiguously
determined. These clones had no BES data, did not contribute
to the sequence assembly and had fingerprints which failed to
significantly match the assembly region expected to contain
the clone. We speculate that localization for these clones failed
due to un-sequenced or unfinished genomic regions.
Clone set representation of the sequence assembly
Coverage of the human genome sequence by the clone set was
assessed using the clone sequence coordinates derived as
described above. BES coordinates were used where available,
and in other cases clone assembly coordinates (21) were pre-
ferred over fingerprint-based placement.
Gaps and undetermined portions in the sequence assembly
were not used in the assessment of sequence coverage of the
clone set. Such regions currently represent an estimated 0.227
Gb (7%) out of a total assembly size of 3.070 Gb. Using the
31 686 clones with sequence coordinates, we determined that
2.827 Gb, corresponding to >99.4% of the assembled sequence
(July 2003), is represented by the clone set (Figure 2). Clones
not found in the BAC fingerprint map, selected to fill in gaps
>10 kb, contribute 18 Mb towards coverage of the genome
sequence. We estimate therefore that the fingerprint map itself
covers 2.809 Gb, or at least 99% of the current sequence
assembly. This is more than the previously predicted coverage
of 96%, computed using analysis of chromosomes 21 and 22
(4), and indicates that, at least in the case of human, the
fingerprint map provides near-complete coverage of the
sequenced portion of the genome. For other mammalian gen-
omes (i.e. rat and mouse) it will be interesting to repeat this
coverage assessment as the genome sequence assemblies
mature.
Excluding regions of the assembly for which sequence
information is known not to be available (e.g. telomeres, cen-
tromeres, internal gaps), our analysis reveals the existence in
the clone set of 526 detectable gaps in sequence coverage,
totalling 13.7 Mb. The gaps arise largely from regions for
which coverage cannot be achieved by using RPCI-11,
RPCI-13 and Caltech-D clones. Of the gaps, 210 are smaller
than 10 kb, and these total 0.7 Mb (Figure 3). Given that clones
from a number of libraries (www.ncbi.nlm.nih.gov/genome/
clone) have been sequenced to generate the human genome
sequence assembly, it is not surprising that the largest gaps are
found in genome regions not represented by clones in the
RPCI-11, RPCI-13 or Caltech-D libraries. It is possible to
address these gaps by including individual clones from
other libraries in future versions of the clone set. Our estima-
tion of gaps likely represents an overestimate of the actual
gaps in the clone set because sequence assembly coordinates
based on in silico mappings are typically smaller than the
actual clone insert size.
Clone set representation of the BAC fingerprint map
Although the calculation of map coverage appears subordinate
to that of assembled sequence coverage, assessment of map
coverage is relevant because some regions of the fingerprint
map may not be represented in the sequence assembly. How-
ever, a precise assessment of fingerprint map coverage by the
clone set is more difficult to determine automatically than such
an assessment of sequence coverage. This is because the
Figure 1. Comparisons of the left end, middle and right end genome sequence
coordinates derived from BAC end sequence data to the coordinates derived
from the fingerprint-based in silico mapping procedure described in the text.
Shown are distributions depicting the frequency of occurrence of differences
in the coordinates. In general, a narrower distribution corresponds to better
correlation between coordinates derived from the BES data and the in silico
approach. Shaded regions indicate the proportion of the comparisons falling
into indicated intervals. The X-axis scale is in kilobases; the Y-axis depicts
number of comparisons. The line indicates the cumulative distribution of the
differences in localization.
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fingerprint map scale metric, measured in cbmap units, is not
locally linear with the sequence scale and because not all
restriction fragments are detected by the fingerprinting method
(2,3). An additional confounding factor is that fingerprints in
the map were processed to remove multiple co-migrating frag-
ments (4). We evaluated coverage of the fingerprint map in
two ways. First, we examined the coverage of the map pro-
vided by the clones in the set in terms of the representation of
contigs as well as of the cbmap unit scale. Second, we eval-
uated the overlap in the fingerprint map between all adjacent
clones in the set using the validation fingerprint data. Briefly,
all fingerprint map contigs larger than 2 clones and containing
clones from RPCI-11, RPCI-13 or Caltech-D are represented
in the clone set. The set provides coverage of 98% of the
cbmap units, with a median cbmap gap of 6. For 1.5% of
adjacent set clones, overlap by fingerprint could not be unam-
biguously inferred. Refer to the Supplementary Material for
additional details.
Resolving power and other properties of the clone set
To determine the spatial resolving power of the clone set, we
computed all unique intersections between clones in the set
using their sequence coordinates. This process can be visual-
ized as locating both ends of each clone on the sequence and
evaluating the distances between closest end positions. This
distance between adjacent ends, which we call a ‘clone cover’,
defines the smallest resolvable region. The average size of
clone covers is 47 kb. The effective resolving power of the
set is 79 kb (Figures 4 and 5), and was calculated using a
weighted average of the clone cover size, where the weights
are given by the fraction of the sequence represented in covers
of a given size. This figure is a reasonable approximation of the
theoretical resolution achievable with this set in array-CGH
experiments [see e.g. (9,22,23)].
Using our analysis of clone covers, we were able to derive
other useful statistics for the clone set. The median sequence
overlap between neighbouring clones is 83 kb, which corre-
sponds to 50% of the length of the clones, with 90% of neigh-
bouring overlaps in the range of 14–160 kb. The average
coverage depth of the clone set, based on sequence coordinates
is 1.9X (Figure 6), which substantiates the calculation we
performed using cbmap units as described above. The ratio
of 1- to 2-fold coverage of the genome is approximately 1:1,
with 1.02 Gb of the sequence assembly spanned by a single
clone and 1.16 Gb spanned by two overlapping clones.
Figure 2. Coverage of the sequence assembly provided by the clones in the set. For each chromosome, the coverage of adjacent 700 kb regions is plotted as a colour
map. Regions in the assembly without sequence information appear as black areas. Bright blue regions correspond to 100% coverage. Distance scale is in megabases.
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Regions spanned at 3-fold coverage total 0.42 Gb, and deep
coverage of at least 4-fold spans 0.19 Gb of the genome
(Figure 6). Coverage at high depth in our clone set typically
occurs in regions where additional clones were added to the set
to replace clones that failed validation, as it was not always
possible to find a single clone providing equivalent coverage
during the replacement process.
The precise determination of telomere representation in
the clone set is complicated by the difficulties in isolating
and sequencing clones derived from them. We attempted to
measure the representation of telomeric regions in the clone
set using 210 unique BAC telomeric markers derived from
the RPCI-11/13 and Caltech-D libraries by the Human
Telomere Sequencing and Mapping Project (24). Out of
the 46 different telomeres (X and Y telomeres are considered
identical), these 210 BACs mark unique sequences near 40
telomeres. Telomeres 13p, 14p, 15p, 21p and 21q are not
represented in this set. Our clone set contains 64 of these 210
telomeric markers, 9 of which do not have explicit sequence
coordinates. Of the remaining 146 markers, 116 are in the
fingerprint map and these BACs overlap (by analysis of
fingerprint data) with the best match in the clone set by
an average of 110 kb (e.g. 102 of the 116 overlap by
>83 kb). The 64 markers included directly in our set and
the clones sharing substantial overlap with the 102 telomere
BAC markers provide good representation of the content of
the BAC telomeric markers. The markers of the 6q telomere
are not represented. We anticipate that by creating a clone
set which represents full coverage of the fingerprint map (as
opposed to only those regions of the map represented by
sequence data), the issue of telomere and centromere rep-
resentation is mitigated somewhat, although genomic regions
un-clonable in BACs, or not present in the map, or
represented only in difficult to obtain and distribute libraries
will not be represented in this version of the clone set.
DISCUSSION
We have created and made available a clone set which repres-
ents at least 99% of the current human genome sequence
assembly. The clone set contains 32 855 clones, with 32 432
already rearrayed from the RPCI-11, RPCI-13 and Caltech-D
libraries and the additional 441, comprising the Version 1.1
clone set update, soon to be made available. The clone set is
portable and affordable, and offers interested researchers the
opportunity to acquire a reasonably complete representation of
the human genome in a modest number (93) of 384-well
plates. We envision various uses of the clone set, including
the development of FISH probes and for BAC array CGH.
Towards this latter goal, we have undertaken a preliminary
validation of the clones in the set, measuring their performance
in array CGH (10).
A potential issue for some users of the clone set is the extent
to which clones in the set could be related to the genome
sequence. Early on during the construction of the clone set,
when the sequence assembly was still evolving, we considered
using only clones sequenced by the Human Genome Sequenc-
ing Project. However, we found that clones populating sequen-
cing queues were frequently not optimal for various reasons.
These included clones of sub-optimal length and clones repre-
sented in libraries not readily available to us and others. The
frequently changing nature of the clones listed in sequencing
queues was likewise confounding. And obviously, if restricted
to only sequenced clones, we would be unable to sample
regions of the genome un-represented in sequenced clones,
Figure 3. Distribution of gaps in sequence coverage. Location and sizes of gaps is determined by using all available sequence coordinates for clones in the set. Of the
gaps, 40% are <10 kb. Many gaps in this distribution may not be real, but instead result from our conservative algorithm for in silico sequence coordinate
determination. There are 1169 BACs without sequence coordinates and therefore without explicit localization in the genome. When the genome sequence is complete
it is possible that many of these BACs will be localized on the sequence.
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Figure 4. Resolution provided by the clones in the set. For each chromosome, the average clone cover size is coded by colour. There are a total of 61 656 clone covers
with an average cover size of 47 kb and an effective resolution of 79 kb. Regions in the assembly without sequence information appear as black areas. Distance scale is
in megabases.
Figure 5. Distribution of clone cover sizes and cumulative distribution of the effective resolution of our clone set. The average effective resolution is 79 kb. This value
is obtained by averaging the cover sizes at randomly sampled points of the sequence assembly. 95% of the genome can be resolved by the clone set at a level of 150 kb,
or better.
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yet represented in the BAC fingerprint map. Finally, the loca-
lization of the ends of even sequenced clones is non-trivial in
cases where the full clone insert has not been finished and
where useful BAC end sequences are not available. For all of
these reasons, we felt that a general method to associate clones
in the set to the genome sequence, even in the absence of
sequence data from the clones, was necessary. The main chal-
lenge was in demonstrating that our fingerprinting procedure
yielded restriction fragment size information that could be
compared directly to in silico fingerprints derived from the
sequence, yielding reliable estimates of clone coordinates and
span on the sequence. This in turn was aided by the fact that
half of the clones in the set could be directly related to the
sequence through either informative BAC end sequences or
the availability of other sequence information. Once we were
satisfied that we could localize clones accurately on the
sequence assembly using a combination of sequence and fin-
gerprint data, we enjoyed substantial flexibility in the selection
of clones.
Version 1 of the clone set has been available through the
BACPAC Resources Center (bacpac.chori.org) since February
2003. Since that time, 18 requests for the entire clone set have
been received. Derivatives of the clone set have also been
produced (www.chori.org/bacpac/pHumanMinSet.htm), often
to represent specific chromosomes or chromosome arms, and
four requests for these have been received. Hence, the resource
is of interest, and we are constructing similar resources for
other organisms of major importance to biomedical research.
As we gain experience with the performance of clones in the
human set, either directly or through the feedback of others, it
is our intention to upgrade the clone set, producing an
enhanced Version 2. Clone annotations (including clone
names, chromosomal and sequence position assignments,
clone covers, plate locations and fingerprint data), views of
the fingerprint map complete with the identities and positions
of selected clones and a UCSC Genome Browser Track are all
available on our web site at mkweb.bcgsc.ca/bacarray.
SUPPLEMENTARY MATERIAL
Supplementary Material is available at NAR Online.
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